A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/1992
10/24/1992	CA2066842A1 Corneal treatment agents
10/23/1992	WO1992018163A1 Medicine for intraocular operation
10/23/1992	CA2085732A1 Pharmaceutical composition for use in intraocular surgery
10/22/1992	DE4112464A1 Verbesserte retard-systeme fuer die zeitverzoegerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-traegermaterial Improved sustained-release systems for the zeitverzoegerte medical and / or biological reusable materials from a depot-traegermaterial
10/22/1992	DE4112303A1 Nitroglycerin, propellant gas-free spray prepn. - stored in container in which the steel parts are made of V4A series steels to inhibit nitroglycerin decomposition
10/21/1992	EP0509968A1 Synthetic polycarboxylates and proteins hydrogels for drug sustained release and process for the production thereof
10/21/1992	EP0509904A1 Microencapsulation of sunscreen products, their preparation process, cosmetic and pharmaceutical compositions containing said microcapsules and their applications
10/21/1992	EP0509761A1 Transdermal composition containing selegiline
10/21/1992	EP0509752A2 Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist
10/21/1992	EP0509606A1 Tableting excipient
10/21/1992	EP0509338A1 Manufacture and use of stable preparations of small-sized liposomes
10/21/1992	EP0509335A1 Gastroresistant pharmaceutical formulations for oral administration containing bile acids
10/21/1992	EP0509122A1 Device for the transdermal administration of protein or peptide drug
10/21/1992	EP0509041A1 Fibrin sealant delivery method
10/21/1992	EP0509009A1 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent.
10/21/1992	EP0321524B1 Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
10/21/1992	CN1065460A Nonsaditive antihistaminics derived from benzimidazoles
10/21/1992	CN1065396A Process for preparation of red-rooted salvia injection
10/20/1992	WO1992018543A1 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
10/20/1992	US5156851 Coated veterinary implants
10/20/1992	US5156850 Dosage form for time-varying patterns of drug delivery
10/20/1992	US5156849 Pharmaceutical composition
10/20/1992	US5156846 Percutaneous drug delivery system
10/20/1992	US5156845 Dry mouth lozenge
10/20/1992	US5156844 For controlled delivery of a neurotransmitter to the brain
10/20/1992	US5156843 Fabric impregnated with functional substances for controlled release
10/20/1992	US5156842 Liquid suspension for oral administration
10/20/1992	US5156839 Covering wound with composition of carboxymethyl cellulose and polyoxyethylene oxide
10/20/1992	US5156833 Powder aerosol composition
10/20/1992	US5156623 Sustained release material and method of manufacturing the same
10/20/1992	US5156601 Blend of polyurethane and decyclized poly(N-vinyl lactam)
10/20/1992	US5156164 Bactericidal iodine polyurethane open-celled foam complex; nonionic spermicidal surfactant; tampons
10/20/1992	CA2065658A1 Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
10/20/1992	CA1309026C Stable 5-fluorouracil compositions
10/20/1992	CA1309025C Topical preparation containing ofloxacin
10/20/1992	CA1309023C Methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same
10/20/1992	CA1309022C Method for the preparation of a sustained release pharmaceutical composition and the composition prepared thereby
10/20/1992	CA1309021C Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols as percutaneous absorption enhancers
10/20/1992	CA1309018C Prolonged release or biologically active polypeptides
10/18/1992	WO1992018108A1 Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material
10/18/1992	CA2108680A1 Improved retard systems for the sustained release of medicinal and/or biological valuable materials from a depot carrier material
10/16/1992	WO1992018143A1 Pharmaceutical compositions against gastric disorders
10/16/1992	WO1992018114A1 Nabumetone powders
10/16/1992	WO1992018109A1 Rapidly soluble solid preparation
10/16/1992	CA2108379A1 Nabumetone powders
10/16/1992	CA2108374A1 Quick-dissolution solid preparation
10/16/1992	CA2065134A1 Transdermal composition
10/15/1992	WO1992017567A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
10/15/1992	WO1992017514A1 Low density microspheres and their use as contrast agents for computed tomography
10/15/1992	WO1992017487A1 5'-phosphatidyl-5-fluorouridine derivative
10/15/1992	WO1992017209A1 Porous solid preparation containing physiologically active protein substance
10/15/1992	WO1992017208A1 An emollient composition
10/15/1992	WO1992017206A1 Wound healing
10/15/1992	WO1992017179A1 Lipid vesicle containing water-in-oil emulsions
10/15/1992	WO1992017174A1 Process for preparing aqueous suspension
10/15/1992	WO1992017170A1 Novel taurine-based pharmaceutical composition for administration by inhalation
10/15/1992	WO1992017167A1 Oral delivery systems for microparticles
10/15/1992	WO1992017165A1 A single dose vaccination system
10/15/1992	WO1992017163A1 Pharmacologically enhanced formulations
10/15/1992	WO1992017162A1 Lyophilized emulsion
10/15/1992	WO1992017160A1 Use of sphingolipids in the preparation of a cosmetic or dermapharmaceutical composition protecting the skin and hair against the harmful effects of atmospheric pollution
10/15/1992	WO1992017130A1 Local immunosuppression by polymer release of defined combinations of immunosuppressants
10/15/1992	WO1992007899A3 Articles having a hydrophilic polymeric shell and method for preparing same
10/15/1992	DE4131678A1 Stabile multiple emulsionen Stable multiple emulsions
10/15/1992	DE4111679A1 Neue cytarabin-derivate, ihre herstellung und verwendung New cytarabine derivatives, their production and use
10/15/1992	CA2116362A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
10/15/1992	CA2107473A1 Porous solid formulations containing proteinaceous physiologically active substances
10/15/1992	CA2106065A1 Emollient composition
10/15/1992	CA2083842A1 Method for preparation of an aqueous suspension
10/15/1992	CA2083825A1 Novel taurine-based pharmaceutical composition for administration by inhalation
10/14/1992	EP0508969A1 Process for conditioning of water-soluble substances
10/14/1992	EP0508756A1 Stabilized vitamin D preparation
10/14/1992	EP0508653A1 Sustained-release pharmaceutical preparation and process for preparing the same
10/14/1992	EP0508435A2 Pharmaceutical composition of stabilized [Leu 13]-motilin-Hse
10/14/1992	EP0508312A1 Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts
10/14/1992	EP0508311A1 Injectable compositions containing 2-oxindole-1-carboxamide derivatives
10/14/1992	EP0508310A1 Pharmaceutical composition for rectal administration, which contains a 2-oxindole-1-carboxamide derivative
10/14/1992	EP0508194A1 Stabilized factor VIII preparations
10/14/1992	EP0508155A1 Process for microencapsulation of products emulsive in water but which are not thermoplastic
10/14/1992	EP0507944A1 Implantable biodegradable material and method for producing same.
10/14/1992	EP0507768A1 Method and composition for treating xerostomia
10/14/1992	EP0500802A4 Liposomal compositions
10/14/1992	CN1018640B Process for the preparation of compounds for the induction of in vivo and in vitro production of cytokines
10/14/1992	CA2106566A1 Stable multiple emulsions
10/13/1992	WO1992018107A1 Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
10/13/1992	US5155246 Wool-wax substitutes
10/13/1992	US5155125 Orally Administering; having an aldose reductase inhibitory activity
10/13/1992	US5154930 Pharmacological agent-lipid solution preparation
10/13/1992	US5154929 Percutaneous absorption type preparation and process for preparing the same
10/13/1992	US5154927 Gum composition containing dispersed porous beads containing active chewing gum ingredients and method
10/13/1992	US5154926 Acetaminophen or phenobarbital syrup composition
10/13/1992	US5154922 Compositions for transdermal delivery of estradiol
10/13/1992	US5154854 Process for the preparation of stable dispersions of at least one water-immiscible liquid phase in an aqueous phase
10/13/1992	US5154853 Alkylating branches of multi-branch core alkyl compound with alkyne building lbock having ether side chains; reducing; deprotecting; functionalizing
10/13/1992	US5154754 Oil-in-water emulsions and a process for their preparation and their use
10/13/1992	EP0517840A4 Device and method for administration of physostigmine.
10/13/1992	CA2065579A1 Stable small particle liposome preparations, their production and use in topical cosmetic and pharmaceutical compositions
10/13/1992	CA1308838C Elastomeric silicone polyaddition composition comprising iodine
10/13/1992	CA1308837C Elastomeric silicone polyaddition composition comprising iodine
10/13/1992	CA1308836C Hot vulcanisable silicone elastomer based composition containing iodine

1 ... 2818 2819 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 ... 2991